A nurse is caring for a client who has cirrhosis of the liver and is receiving spironolactone. Which of the following findings indicates that the client responding to the treatment?

A) Dry cough:
Dry cough is not a common adverse effect of metoclopramide. It is more commonly associated with medications such as angiotensin-converting enzyme (ACE) inhibitors.

B) Tardive dyskinesia:
Tardive dyskinesia is a serious adverse effect associated with long-term use of metoclopramide, especially at high doses or with prolonged therapy. It manifests as involuntary, repetitive movements of the face, tongue, or extremities and can be irreversible.

C) Black stools:
Black stools may indicate gastrointestinal bleeding, which can occur as a result of various factors, including peptic ulcer disease or gastrointestinal irritation. While gastrointestinal adverse effects can occur with metoclopramide, they typically present as diarrhea rather than black stools.

D) Oral candidiasis:
Oral candidiasis, or oral thrush, is a fungal infection of the mouth caused by Candida species. It is not a direct adverse effect of metoclopramide.

A) Massage the injection site after administering the medication:
Massaging the injection site after administering enoxaparin or any other medication is not recommended. It could potentially disrupt the absorption of the medication or cause tissue damage at the injection site. Therefore, this action is incorrect.

B) Hold the skin taut at the injection site while administering the medication:
Holding the skin taut at the injection site is not necessary for administering enoxaparin. Unlike some intramuscular injections, enoxaparin is typically administered subcutaneously, and holding the skin taut may not be required. This action is unnecessary and not part of the standard procedure for administering enoxaparin.

C) Administer the medication into the anterolateral or posterolateral abdominal area:
This is the correct action. Enoxaparin is usually administered subcutaneously into the anterolateral or posterolateral abdominal area. These sites have a layer of adipose tissue that allows for absorption of the medication. Administering enoxaparin into these areas helps minimize the risk of injury to underlying structures and ensures optimal absorption of the medication.

D) Expel the air bubble from the syringe prior to administering the medication:
While expelling air bubbles from the syringe is a standard practice when preparing medications for injection, it is not specifically related to the administration of enoxaparin. However, ensuring that the syringe is free of air bubbles before injection is still important to prevent air embolism or inaccurate dosing. Therefore, while this action is generally appropriate, it does not address the specific administration technique for enoxaparin.